(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 5.14% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Zimmer Biomet Holdings's revenue in 2025 is $7,833,800,000.On average, 11 Wall Street analysts forecast ZBH's revenue for 2025 to be $1,626,905,264,949, with the lowest ZBH revenue forecast at $1,611,568,277,675, and the highest ZBH revenue forecast at $1,633,043,863,301. On average, 11 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,721,024,628,867, with the lowest ZBH revenue forecast at $1,693,128,356,208, and the highest ZBH revenue forecast at $1,747,800,866,832.
In 2027, ZBH is forecast to generate $1,800,118,412,398 in revenue, with the lowest revenue forecast at $1,754,849,121,943 and the highest revenue forecast at $1,848,209,778,242.